Thirty-Day Mortality Following Systemic Anticancer Therapy: Evaluating Risk Factors Without Selection Bias in a Real-World, Population-Based Cohort From 2009 to 2019

Autor: C. Vesteghem, R.F. Brøndum, M.T. Mouritzen, H.S. Christensen, M. Bøgsted, U.G. Falkmer, L.Ø. Poulsen

Publikováno v: Vesteghem, C, Brøndum, R F, Mouritzen, M T, Christensen, H S, Bøgsted, M, Falkmer, U G & Poulsen, L Ø 2022, ' Thirty-Day Mortality Following Systemic Anticancer Therapy : Evaluating Risk Factors Without Selection Bias in a Real-World, Population-Based Cohort From 2009 to 2019 ', Clinical Oncology, vol. 34, no. 8, pp. 487-496 . https://doi.org/10.1016/j.clon.2022.03.015

AIMS: Risk factors for systemic anticancer therapies (SACTs) administered close to death derived from existing quality indicators are not directly applicable in the clinic, because they condition on future events, which leads to selection bias. This

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3cd7300462be986ffeda167cb6719ec
https://doi.org/10.1016/j.clon.2022.03.015

P653 The changing epidemiology of IBD in the western world: a population-based study from Denmark

Autor: M Agrawal, H Christensen, M Bøgsted, J F Colombel, T Jess, K Allin

Publikováno v: Journal of Crohn's and Colitis. 16:i566-i567

Background Mitigating the burden of inflammatory bowel disease (IBD) in Western countries requires understanding how its epidemiology is evolving. We conducted a temporal analysis of the epidemiology of IBD between 1995 and 2018 in the Danish nationw

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c3cf96e628ad55b5e1d701fce4d67396
https://doi.org/10.1093/ecco-jcc/jjab232.774

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.